January 30, 2015 12:41 PM ET


Company Overview of PharmEste s.r.l.

Company Overview

PharmEste s.r.l., a biopharmaceutical company, focuses on the discovery and development of transient receptor potential (TRP) channel therapeutics for the treatment of neuropathic pain, overactive bladder, and other TRP-mediated diseases. It develops PHE377, a TRPV1 antagonist for the treatment of neuropathic pain. The company was founded in 2003 and is based in Bresso, Italy.

Via Ariosto 21

Bresso, MI 20091


Founded in 2003


39 02 66 52 45 50


39 02 66 52 45 47

Key Executives for PharmEste s.r.l.

Chief Executive Officer
Chief Financial and Business Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Sicor Soc Italiana Corticosteroidi Srl Europe
Vétoquinol Italy Europe
Bayer Biologicals S.r.l. Europe
Wyeth Consumer Healthcare S.p.A. Europe
Sigma-Tau HealthScience S.p.A. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PharmEste s.r.l., please visit www.pharmeste.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.